Birgit Scheel

Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients

Benjamin Weide, Steve Pascolo, Birgit Scheel et al. · Journal of Immunotherapy · 2009 · 380 citations

Medicine, Immunology, Oncology +17

Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study

Hubert Kübler, Birgit Scheel, Ulrike Gnad-Vogt et al. · Journal for ImmunoTherapy of Cancer · 2015 · 284 citations · Full text

Veterinary Medicine, Immunology, Oncology +17

Results of the First Phase I/II Clinical Vaccination Trial With Direct Injection of mRNA

Benjamin Weide, Jean‐Philippe Carralot, Anne Reese et al. · Journal of Immunotherapy · 2008 · 258 citations

Medicine, Immunology, Oncology +17

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer

Alexandros Papachristofilou, M. Hipp, Ute Klinkhardt et al. · Journal for ImmunoTherapy of Cancer · 2019 · 222 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent

Jochen Probst, Benjamin Weide, Birgit Scheel et al. · Gene Therapy · 2007 · 206 citations

Life Sciences, Biochemistry, Molecular Biology +6